Atlas Trials

A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets

Clinical trial NCT07647783 · RECRUITING

Trial details

NCT number
NCT07647783
Sponsor
InnovStone Therapeutics Limited
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2026-01-15
Primary completion
2027-02-01
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.